您现在的位置:生物医药大词典 >> 英汉双语句子大全 >> 的意思
the average stereopsis used by Titmus is 8.89S,and Frisby is 8.S. Increase along with the age,the growth of stereopsis is too gradually mature;
中文意思:
Titm us平均立体视为 8 .89S,Frisby平均立体视为 8. S,随着年龄的增长 ,立体视的发育也渐趋成熟 ;


以下为相关句子列表(点击查看,可以看对应的解释):
the activities of GST were the highest in %-0% and %-% of PEG0000 fractionation for midgut and fat body, respectively. The specific activities of GST were 77.7 and 9.9 nmol/(min·mg) respectively, and the purification factors were .8-fold and .0-fold. PEG0000沉淀中肠和脂肪体GST的活性峰分别在%~0%和%~%, 比活力分别是77.7和9.9 nmol (min·mg), 纯化倍数分别是.8和 . 0。
the antero-lateral of dentary bearing prominent angles. 齿骨前背缘有外侧角等。
the antisepsis and placing the containers and wrappers; 成品容器及包装袋的洗刷消毒和存放;
the appearance of anti HBe can not be taken as indicator of ceasing of HBV replication; 抗 HBe的出现不能作为HBV复制停止的指标 ;
the average recovery rate of estriol was99.%(RSD=0.,n=). 平均回收率为99 % ,RSD=0 % (n=)。
the average stereopsis used by Titmus is 8.89S,and Frisby is 8.S. Increase along with the age,the growth of stereopsis is too gradually mature; Titm us平均立体视为 8 .89S,Frisby平均立体视为 8. S,随着年龄的增长 ,立体视的发育也渐趋成熟 ;
the average voided volume was (0 ±) vs (7±) mL per second (P <0.0); 平均尿量分别为(0 ±)mL/次和(7±)mL/次(P<0.0);
the averages values of pustules, papules and comedones decreased from . 0, 7.9 and . to 0. 7, . and . respectively. 脓疱、丘疹、粉刺数的平均值分别由.0、7.9和 . 个减至0.7、 . 和.个。
the back-cross results of heterozygote F with its parents suggested that the separation of progenies F (SR♀× S♂ and RS♀× R♂) was consistent with Mendel’s single gene inheritance model. 对F 杂合子与亲本的回交(SR♀×S♂和RS♀×R♂)F代测定表明抗性由单基因控制。
the best conditions of oral liquid of turkey ossein peptide: turkey ossein peptide is 0%, Xylitol is .0% and honey is %. 火鸡骨胶原蛋白多肽口服液最佳配方:火鸡骨胶原蛋白多肽液0%、木糖醇.0%、蜂蜜%。
the best conditions of preparation with pepsin were: ℃,m(pepsin)∶m(pig skin)=∶0, 7hours; 酶提取的最优条件为:℃,m(酶)∶m(原料)=∶0,7h;
 
你知道它的英文吗?
你知道中文意思吗?
热门分类


成为编辑 - 词典APP下载 - 关于 - 推荐 - 手机词典 - 隐私 - 版权 -链接 - 联系 - 帮助
©2008-至今 生物医药大词典- 自2008年3月1日开始服务 生物谷www.bioon.com团队研发
沪ICP备14018916号-1